New drug candidate offers hope for patients with NRAS-driven melanoma
A Huntsman Cancer Institute team at the University of Utah reports that daraxonrasib, a targeted RAS inhibitor, could offer a ...
A Huntsman Cancer Institute team at the University of Utah reports that daraxonrasib, a targeted RAS inhibitor, could offer a ...
TAMPA, Fla. (August 18, 2025) — In a significant advancement for melanoma treatment, researchers at Moffitt Cancer Center have uncovered ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine